Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (Feb 8, 2018)
  • 8-K (Jan 8, 2018)
  • 8-K (Dec 22, 2017)
  • 8-K (Dec 6, 2017)
  • 8-K (Nov 13, 2017)
  • 8-K (Nov 9, 2017)

 
Other

Immunomedics 8-K 2010

Documents found in this filing:

  1. 8-K
  2. 8-K
Unassociated Document
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_______________________________
 
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): June 30, 2010
 
Immunomedics, Inc.
(Exact Name of Registrant as Specified in Charter)
 
 
Delaware 000-12104 61-1009366
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
 
(IRS Employer Identification No.)
 
 
 
 
300 American Road, Morris Plains, New Jersey 07950
(Address of Principal Executive Offices)
(Zip Code)
 
(973) 605-8200
(Registrant's telephone number,
including area code)

Not applicable
(Former Name or Former Address, if Changed Since Last Report)
 
 
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
[ ]    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425).
[ ]    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12).
[ ]    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)).
[ ]    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).

 
 

 
Item 8.01                      Other Events.
 
Effective June 30, 2010, Immunomedics, Inc. (the “Company”) terminated the services of American Stock Transfer and Trust Company as the Company’s transfer agent and registrar for shares of the Company’s common stock $0.01 par value per share (the “Common Stock”), and appointed StockTrans, Inc. to serve as the Company’s transfer agent and registrar for shares of the Company’s Common Stock.  Contact information for the Company’s transfer agent is as follows:
 
StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
800-733-1121
 

 
 

 

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
IMMUNOMEDICS, INC.
 
 
   By:   /s/ Cynthia L. Sullivan
     Name:  Cynthia L. Sullivan
     Title:  President and Chief Executive Officer
 
Dated:           June 30, 2010
 

 
 

 

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki